Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 30, Issue 8, 2016, Pages 1067-1078

  Andersson, Maria ^a   Diao, Xingxing ^a   Wohlfarth, Ariane ^a,b,c   Scheidweiler, Karl B ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b DEPARTMENT OF FORENSIC GENETICS AND FORENSIC TOXICOLOGY   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; DRUG PRODUCTS; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY;

HIGH RESOLUTION MASS SPECTROMETRY; HUMAN HEPATOCYTES; HUMAN LIVER; HUMAN LIVER MICROSOMES; INDAZOLE; LIVER MICROSOMES; METABOLIC PROFILING; STRUCTURAL ANALOGUE; SYNTHETIC CANNABINOID; [CARBONYL;

METABOLITES;

CANNABINOID;

CELL CULTURE; CHEMISTRY; HUMAN; LIVER CELL; LIVER MICROSOME; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; PROCEDURES;

CANNABINOIDS; CELLS, CULTURED; HEPATOCYTES; HUMANS; MASS SPECTROMETRY; METABOLOMICS; MICROSOMES, LIVER;

EID: 84961777980     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.7538     Document Type: Article

References (42)

1. EMCDDA. European drug report 2015: trends and developments. Available: http://www.emcdda.europa.eu/publications/edr/trends-developments/2015/online/start (accessed November 30 2015).
2. Review FD (2014). Available: http://www.forensicdrugreview.com/15 (accessed December 15 2014).
3. Review FD (2014). Available: http://www.forensicdrugreview.com/16 (accessed December 16 2014).
4. A. Wohlfarth, M. S. Castaneto, M. Zhu, S. Pang, K. B. Scheidweiler, R. Kronstrand, M. A. Huestis,. Pentylindole/pentylindazole synthetic cannabinoids and their 5-fluoro analogs produce different primary metabolites: Metabolite profiling for AB-PINACA and 5F-AB-PINACA. AAPS J. 2015, 17, 660.
5. N. Uchiyama, Y. Shimokawa, M. Kawamura, R. Kikura-Hanajiri, T. Hakamatsuka,. Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol. 2014, 32, 266.
6. K. Hasegawa, A. Wurita, K. Minakata, K. Gonmori, H. Nozawa, I. Yamagishi, K. Watanabe, O. Suzuki,. Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol. 2015, 33, 45.
7. C. Hess, S. Stockhausen, G. Kernbach-Wighton, B. Madea,. Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids? Forensic Sci. Int. 2015, 257, e6.
8. Administration CfaD, 2015. Available: http://www.sfda.gov.cn/WS01/CL0056/130753.html (accessed November 2015).
9. Protection FMoJaC, 2015. Available: http://www.gesetze-im-internet.de/btmg-1981/anlage-ii.html (accessed November 2015).
10. NIoH Data Search System for New Psychoactive Substances. Available: http://npsdb.nihs.go.jp/Search/Default-e.aspx (accessed November 2015).
11. Act SSMoD, 2015. Available: http://statutes.agc.gov.sg/aol/search/display/view.w3p;ident=db7c4f61-fcdc-4b0f-9923-644fd82fcafe;page=0;query=CompId%3Aa64ce13f-cdeb-48cc-85d5-850d4f4c434d;rec=0 (accessed November 2015)
12. NIoH (2014) Data Search System for New Psychoactive Substances. Available: http://npsdb.nihs.go.jp/Search/Search/Detail-e.aspx?name=AMB&url=AllCompounds (accessed December 2015).
13. M. S. Castaneto, A. Wohlfarth, N. A. Desrosiers, R. L. Hartman, D. A. Gorelick, M. A. Huestis,. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metab. Rev. 2015, 47, 124.
14. T. Sobolevsky, I. Prasolov, G. Rodchenkov,. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 2010, 200, 141.
15. K. B. Scheidweiler, M. J. Jarvis, M. A. Huestis,. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Anal. Bioanal. Chem. 2015, 407, 883.
16. M. S. Castaneto, A. Wohlfarth, S. K. Pang, M. S. Zhu, K. B. Scheidweiler, R. Kronstrand, M. A. Huestis,. Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry. Forensic Toxicol. 2015, 33, 295.
17. K. C. Chimalakonda, K. A. Seely, S. M. Bratton, L. K. Brents, C. L. Moran, G. W. Endres, L. P. James, P. F. Hollenberg, P. L. Prather, A. Radominska-Pandya, J. H. Moran,. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metab. Dispos. 2012, 40, 2174.
18. X. Diao, X. Pang, C. Xie, Z. Guo, D. Zhong, X. Chen,. Bioactivation of 3-n-butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP: mediated mainly by sulfotransferase 1A1. Drug Metab. Dispos. 2014, 42, 774.
19. Y. Ito, R. Okada, H. Mochida, H. Hayashi, K. Yamamoto, S. Kikuyama,. Molecular cloning of bullfrog corticotropin-releasing factor (CRF): effect of homologous CRF on the release of TSH from pituitary cells in vitro. Gen. Comp. Endocrinol. 2004, 138, 218.
20. P. Baranczewski, A. Stanczak, K. Sundberg, R. Svensson, A. Wallin, J. Jansson, P. Garberg, H. Postlind,. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 2006, 58, 453.
21. M. G. Soars, D. F. McGinnity, K. Grime, R. J. Riley,. The pivotal role of hepatocytes in drug discovery. Chem. Biol. Interact. 2007, 168, 2.
22. A. S. Gandhi, M. Zhu, S. Pang, A. Wohlfarth, K. B. Scheidweiler, H. F. Liu, M. A. Huestis,. First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. AAPS J. 2013, 15, 1091.
23. M. J. Swortwood, J. Carlier, K. N. Ellefsen, A. Wohlfarth, X. Diao, M. Concheiro-Guisan, R. Kronstrand, M. A. Huestis,. In vitro, in vivo and in silico metabolic profiling of alpha-pyrrolidinopentiothiophenone, a novel thiophene stimulant. Bioanalysis 2016, 8, 65.
24. K. N. Ellefsen, A. Wohlfarth, M. J. Swortwood, X. Diao, M. Concheiro, M. A. Huestis,. 4-Methoxy-alpha-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicol. 2016, 34, 61.
25. X. Diao, K. B. Scheidweiler, A. Wohlfarth, S. Pang, R. Kronstrand, M. A. Huestis,. In vitro and in vivo human metabolism of synthetic cannabinoids FDU-PB-22 and FUB-PB-22. AAPS J. 2016. DOI: 10.1208/s12248-016-9867-4.
26. M. Zhu, H. Zhang, W. G. Humphreys,. Drug metabolite profiling and identification by high-resolution mass spectrometry. J. Biol. Chem. 2011, 286, 25419.
27. C. A. McNaney, D. M. Drexler, S. Y. Hnatyshyn, T. A. Zvyaga, J. O. Knipe, J. V. Belcastro, M. Sanders,. An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion. Assay Drug Dev. Technol. 2008, 6, 121.
28. R. Thomsen, L. M. Nielsen, N. B. Holm, H. B. Rasmussen, K. Linnet, Consortium I. Synthetic cannabimimetic agents metabolized by carboxylesterases. Drug Test. Anal. 2015, 7, 565.
29. W. Tang,. The metabolism of diclofenac-enzymology and toxicology perspectives. Curr. Drug Metab. 2003, 4, 319.
30. X. Diao, Z. Ma, H. Wang, D. Zhong, Y. Zhang, J. Jin, Y. Fan, X. Chen,. Simultaneous quantitation of 3-n-butylphthalide (NBP) and its four major metabolites in human plasma by LC-MS/MS using deuterated internal standards. J. Pharm. Biomed. Anal. 2013, 78/79, 19.
31. T. Lave, S. Dupin, C. Schmitt, B. Valles, G. Ubeaud, R. C. Chou, D. Jaeck, P. Coassolo,. The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans. Pharm. Res. 1997, 14, 152.
32. X. Diao, P. Deng, C. Xie, X. Li, D. Zhong, Y. Zhang, X. Chen,. Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans: the role of cytochrome P450s and alcohol dehydrogenase in biotransformation. Drug Metab. Dispos. 2013, 41, 430.
33. A. K. Sohlenius-Sternbeck, H. V. Chelpin, A. Orzechowski, M. M. Halldin,. Metabolism of sameridine to monocarboxylated products by hepatocytes isolated from the male rat. Drug Metab. Dispos. 2000, 28, 695.
34. S. Zhong, R. Jones, W. Lu, S. Schadt, G. Ottaviani,. A new rapid in vitro assay for assessing reactivity of acyl glucuronides. Drug Metab. Dispos. 2015, 43, 1711.
35. S. L. Regan, J. L. Maggs, T. G. Hammond, C. Lambert, D. P. Williams, B. K. Park,. Acyl glucuronides: the good, the bad and the ugly. Biopharm. Drug Dispos. 2010, 31, 367.
36. X. Diao, A. Wohlfarth, S. Pang, K. B. Scheidweiler, M. A. Huestis,. High-resolution mass spectrometry for characterizing the metabolism of synthetic cannabinoid THJ-018 and its 5-fluoro analog THJ-2201 after incubation in human hepatocytes. Clin. Chem. 2016, 62, 157.
37. A. Wohlfarth, A. S. Gandhi, S. Pang, M. Zhu, K. B. Scheidweiler, M. A. Huestis,. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Anal. Bioanal. Chem. 2014, 406, 1763.
38. M. Hutter, B. Moosmann, S. Kneisel, V. Auwarter,. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J. Mass Spectrom. 2013, 48, 885.
39. A. Wohlfarth, S. Pang, M. Zhu, A. S. Gandhi, K. B. Scheidweiler, H. F. Liu, M. A. Huestis,. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clin. Chem. 2013, 59, 1638.
40. J. Ding, X. Chen, Z. Gao, X. Dai, L. Li, C. Xie, H. Jiang, L. Zhang, D. Zhong,. Metabolism and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor apatinib in humans. Drug Metab. Dispos. 2013, 41, 1195.
41. H. K. Uldam, M. Juhl, H. Pedersen, L. Dalgaard,. Biosynthesis and identification of an N-oxide/N-glucuronide metabolite and first synthesis of an N-O-glucuronide metabolite of Lu AA21004. Drug Metab. Dispos. 2011, 39, 2264.
42. H. Ibrahim, F. Couderc, P. Perio, F. Collin, F. Nepveu,. Behavior of N-oxide derivatives in atmospheric pressure ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2013, 27, 621.